参考文献/References:
[1]中国医师协会急诊医师分会.中国急诊重症肺炎临床实践专家共识[J].中国急救医学,2016,36(2):97-107.[2]Lim WS,Baudouin SV,George RC,et al.BTS guidelines for the management of community acquired pneumonia in adults: update 2009[J].Thorax,2009,64 Suppl 3:iii1-55.[3]Salih W,Schembri S,Chalmers JD.Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data[J].Eur Respir J,2014,43(3):842-851.[4]梅海霞,唐玉珍,杨辉,等.老年重症肺炎患者的临床特征,病原菌分布以及影响患者死亡的危险因素分析[J].实用预防医学,2019,26(3):102-104.[5]Huang DT,Yealy DM,Filbin MR,et al.Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection[J].N Engl J Med,2018,379(3):236-249.[6]Schuetz P,Wirz Y,Mueller B.Procalcitonin Testing to Guide Antibiotic Therapy in Acute Upper and Lower Respiratory Tract Infections[J].JAMA,2018,319(9):925-926.[7]中华医学会呼吸病学分会呼吸危重症医学学组,中国医师协会呼吸医师分会危重症医学工作委员会. ICU患者支气管肺泡灌洗液采集、送检、检测及结果解读规范[J].中华结核和呼吸杂志,2020,43(9):744-756.[8]张浩,朱婉玲,贾金广.ICU呼吸机相关性肺炎患者血清及肺泡灌洗液中IL-32、PCT的表达及其临床价值[J].中国实用医刊,2019(24):47-50.[9]Donnelly JP,Chen SC,Kauffman CA,et al.Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium[J].Clin Infect Dis,2020,71(6):1367-1376.[10]中国医药教育协会真菌病专业委员会,国家皮肤与免疫疾病临床医学研究中心(北京大学第一医院),国家血液疾病临床医学研究中心(北京大学人民医院).侵袭性真菌病实验室诊断方法临床应用专家共识[J].中华内科杂志,2022,61(2):134-141.[11]Patterson TF,Thompson GR 3rd,Denning DW,et al.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America[J].Clin Infect Dis,2016,63(4):e1-e60.[12]中国医药教育协会感染疾病专业委员会.降钙素原指导抗菌药物临床合理应用专家共识[J].中华医学杂志,2020,100(36):2813-2821.[13]Li Y,Min L,Zhang X.Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children[J].BMC Pulm Med,2021,21(1):386.[14]中华医学会儿科学分会医院感染管理与控制专业委员会.血清降钙素原检测在儿童感染性疾病中的临床应用专家共识[J].中华儿科杂志,2019,57(1):9-15.[15]Schuetz P,Beishuizen A,Broyles M,et al.Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use[J].Clin Chem Lab Med,2019,57(9):1308-1318.[16]Yan ST,Sun LC,Jia HB,et al.Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria[J].Am J Emerg Med,2017,35(4):579-583.[17]Thomas-Rüddel DO,Poidinger B,Kott M,et al.Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia[J].Crit Care,2018,22(1):128.[18]Leli C,Ferranti M,Moretti A,et al.Procalcitonin levels in gram positive,gram negative,and fungal bloodstream infections[J].Dis Markers,2015,2015:701480.[19]Kubo S,Iwasaki M,Horie M,et al.Biological variation of procalcitonin levels in hemodialysis patients[J].Clin Exp Nephrol,2019,23:402.[20]Hausfater P.Biomarkers and infection in the emergency unit[J].Med Mal Infect,2014,44(4):139-145.
相似文献/References:
[1]吴君华,吴友茹,李 丹.血清降钙素原在AECOPD抗感染治疗中的应用价值研究[J].医学信息,2018,31(02):74.[doi:10.3969/j.issn.1006-1959.2018.02.025]
WU Jun-hua,WU You-ru,LI Dan.Study on the Application Value of Serum Calcitonin in the Anti Infection Treatment of AECOPD[J].Journal of Medical Information,2018,31(11):74.[doi:10.3969/j.issn.1006-1959.2018.02.025]
[2]刘 亮.PCT和CRP联合检测对儿童呼吸道感染的临床意义[J].医学信息,2018,31(02):154.[doi:10.3969/j.issn.1006-1959.2018.02.059]
LIU Liang.Clinical Significance of Combined Detection of PCT and CRP in Children with Respiratory Tract Infection[J].Journal of Medical Information,2018,31(11):154.[doi:10.3969/j.issn.1006-1959.2018.02.059]
[3]高艳飞.降钙素原对新生儿感染性肺炎的早期诊断价值研究[J].医学信息,2018,31(03):154.[doi:10.3969/j.issn.1006-1959.2018.03.056]
GAO Yan-fei.Study on the Value of Procalcitonin in the Early Diagnosis of Neonatal Infectious Pneumonia[J].Journal of Medical Information,2018,31(11):154.[doi:10.3969/j.issn.1006-1959.2018.03.056]
[4]李 娟,田 鹏,刘 琦,等.血清降钙素原在儿童发热性疾病中的应用价值分析[J].医学信息,2018,31(04):102.[doi:10.3969/j.issn.1006-1959.2018.04.034]
LI Juan,TIAN Peng,LIU Qi,et al.Analysis of the Value of Serum Procalcitonin in Children with Febrile Diseases[J].Journal of Medical Information,2018,31(11):102.[doi:10.3969/j.issn.1006-1959.2018.04.034]
[5]付云杰.超敏C反应蛋白、前清蛋白及降钙素原在重症肺炎患者中的变化及诊断的临床意义[J].医学信息,2018,31(24):84.[doi:10.3969/j.issn.1006-1959.2018.24.022]
FU Yun-jie.Changes of Hypersensitive C-reactive Protein,Proalbumin and Procalcitonin in Patients with Severe Pneumonia and Its Clinical Significance[J].Journal of Medical Information,2018,31(11):84.[doi:10.3969/j.issn.1006-1959.2018.24.022]
[6]刘伟娜.CD64感染指数、BODE指数与降钙素原在慢阻肺患者中的水平变化[J].医学信息,2019,32(06):125.[doi:10.3969/j.issn.1006-1959.2019.06.039]
LIU Wei-na.Changes of CD64 Infection Index,BODE Index and Procalcitonin Levels in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(11):125.[doi:10.3969/j.issn.1006-1959.2019.06.039]
[7]田 刚,丁俊杰,宋 敏,等.两种不同检测系统测定血清降钙素原的比较实验研究[J].医学信息,2019,32(06):169.[doi:10.3969/j.issn.1006-1959.2019.06.055]
TIAN Gang,DING Jun-jie,SONG Min,et al.Comparative Experimental Study on Serum Procalcitonin by Two Different Detection Systems[J].Journal of Medical Information,2019,32(11):169.[doi:10.3969/j.issn.1006-1959.2019.06.055]
[8]张文旭,徐 绸.红细胞宽度对脓毒症患者病情诊断及预后评估的价值[J].医学信息,2022,35(14):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
ZHANG Wen-xu,XU Chou.The Value of Red-blood-cell Distribution Width in the Diagnosis and Prognosis of Patients with Sepsis[J].Journal of Medical Information,2022,35(11):71.[doi:10.3969/j.issn.1006-1959.2022.14.015]
[9]朱津津.PCT 联合SAA在急性胆管炎患者诊疗中的价值[J].医学信息,2019,32(18):170.[doi:10.3969/j.issn.1006-1959.2019.18.060]
ZHU Jin-jin.The Value of PCT Combined with SAA in the Diagnosis and Treatment of
Patients with Acute Cholangitis[J].Journal of Medical Information,2019,32(11):170.[doi:10.3969/j.issn.1006-1959.2019.18.060]
[10]牛瑞兵.中性粒细胞CD64、PCT联合CRP诊断儿童脓毒血症的价值[J].医学信息,2019,32(19):180.[doi:10.3969/j.issn.1006-1959.2019.19.061]
NIU Rui-bing.The Value of Neutrophil CD64,PCT Combined with CRP in the Diagnosis of Sepsis in Children[J].Journal of Medical Information,2019,32(11):180.[doi:10.3969/j.issn.1006-1959.2019.19.061]